Amyotrophic Lateral Sclerosis - 319 Studies Found

Recruiting : Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation
: Amyotrophic Lateral Sclerosis
: 2016-05-24
:
  • Drug: NP001
  • Drug: Placebo
Completed : Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)
: Sporadic Amyotrophic Lateral Sclerosis
: 2013-05-06
:
  • Drug: Mexiletine Other Name: M
Completed : Hyperlipidemia and Statin Therapy in Amyotrophic Lateral Sclerosis
: Amyotrophic Lateral Sclerosis
: 2012-04-13
Completed : Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)
: Amyotrophic Lateral Sclerosis (ALS)
: 2013-06-19
:
  • Drug: Basiliximab 20 mg, IV (i
Withdrawn : Magnetic Resonance Imaging (MRI) in Amyotrophic Lateral Sclerosis (ALS)
: Amyotrophic Lateral Sclerosis (ALS)
: 2013-09-16
: Device: 7 Tesla MRI
Active, not recruiting : Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)
: Amyotrophic Lateral Sclerosis (ALS)
: 2012-11-28
:
  • Drug: Rasagiline Rasagiline 2m
Not yet recruiting : Circulating Biomarker for Amyotrophic Lateral Sclerosis (ALS)
: Amyotrophic Lateral Sclerosis (ALS)
: 2017-03-13
Completed : F 18 T807 Tau PET Imaging in Familial Amyotrophic Lateral Sclerosis
: Amyotrophic Lateral Sclerosis (ALS)
: 2015-04-07
: Drug: Drug: F 18 T807 Participants will receive a single intravenous bolus injection of approximately 6.
Completed : Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS]
: Amyotrophic Lateral Sclerosis (ALS)
: 2005-09-13
: Drug: Tamoxifen
Completed : Safety, Tolerability, and Activity Study of ISIS SOD1Rx to Treat Familial Amyotrophic Lateral Sclerosis (ALS) Caused by SOD1 Gene Mutations
: Familial Amyotrophic Lateral Sclerosis
: 2009-12-30
: Drug: ISIS 333611 5 arms of 12 hour infusion: Arm 1 0.15 mg, Arm 2 0.5 mg, Arm 3 1.5 mg, Arm 4 3.0 mg, m
<<< Previous | Next >>>